Anthem Biosciences Financials
NSE: ANTHEM | BSE: 544449
₹942.95
₹-14.85
(-1.55%)
As on 09-Sep-2026 15:59IST
Market cap
₹53,704 Cr
Revenue (TTM)
₹2,002 Cr
P/E Ratio
93.2
P/B Ratio
17.2
Div. Yield
0.2 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
2,002.34
|
2,124.33
|
1,844.55
|
1,419.37
|
1,056.92
|
1,231.26
|
|
|
|
|
|
|
Total Income
|
2,160.20
|
2,280.12
|
1,930.29
|
1,483.07
|
1,141.97
|
1,280.24
|
|
|
|
|
|
|
Total Expenditure
|
1,209.46
|
1,290.36
|
1,173.52
|
914.27
|
634.05
|
664.15
|
|
|
|
|
|
|
EBITDA
|
792.89
|
833.97
|
671.03
|
505.10
|
422.87
|
567.10
|
|
|
|
|
|
|
Depreciation
|
137.61
|
134.07
|
89.37
|
81.82
|
63.70
|
57.76
|
|
|
|
|
|
|
EBIT
|
655.28
|
699.90
|
581.66
|
423.28
|
359.18
|
509.35
|
|
|
|
|
|
|
Interest
|
6.17
|
7.06
|
10.53
|
9.66
|
8.72
|
12.19
|
|
|
|
|
|
|
Other Income
|
157.86
|
155.78
|
85.73
|
63.70
|
85.04
|
48.98
|
|
|
|
|
|
|
Exceptional Items
|
-24.39
|
-24.39
|
--
|
--
|
61.80
|
--
|
|
|
|
|
|
|
Profit before Tax
|
782.58
|
824.24
|
656.87
|
477.32
|
497.30
|
546.14
|
|
|
|
|
|
|
Provision for Tax
|
206.63
|
232.45
|
205.61
|
110.01
|
112.11
|
140.60
|
|
|
|
|
|
|
Profit after Tax
|
575.95
|
591.79
|
451.26
|
367.31
|
385.19
|
405.54
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
575.94
|
591.79
|
451.26
|
367.31
|
385.19
|
405.54
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
3,042.52
|
3,042.52
|
2,409.87
|
1,924.66
|
1,740.67
|
1,355.00
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
61.06
|
33.74
|
53.54
|
93.44
|
85.01
|
21.74
|
|
|
|
|
|
|
Current Liabilities
|
325.71
|
529.71
|
485.23
|
458.63
|
278.87
|
349.19
|
|
|
|
|
|
|
Total Liabilities
|
3,429.29
|
3,633.29
|
2,966.58
|
2,518.11
|
2,129.46
|
1,741.87
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
1,421.55
|
1,598.82
|
1,301.47
|
875.17
|
666.38
|
509.62
|
|
|
|
|
|
|
Current Assets
|
1,803.15
|
2,007.15
|
1,647.17
|
1,601.55
|
1,438.17
|
1,216.31
|
|
|
|
|
|
|
Total Assets
|
3,429.29
|
3,633.29
|
2,966.58
|
2,518.11
|
2,129.46
|
1,741.87
|
|
|
|
|
|
|
Total Debt*
|
--
|
51.07
|
108.96
|
232.53
|
125.07
|
35.49
|
|
|
|
|
|
|
Net Current Assets
|
1,477.43
|
1,477.43
|
1,161.94
|
1,142.93
|
1,159.30
|
867.12
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
90.20
|
54.44
|
250.14
|
226.00
|
5.55
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
844.49
|
270.55
|
140.15
|
305.99
|
332.91
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-701.62
|
-146.56
|
-221.46
|
-376.02
|
-205.45
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-40.00
|
-135.65
|
-77.18
|
63.97
|
180.68
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
102.87
|
-11.66
|
-158.49
|
-6.06
|
308.14
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
10.56
|
10.54
|
8.07
|
6.57
|
6.75
|
7.11
|
|
|
|
|
|
|
Cash EPS (₹)
|
10.22
|
12.92
|
9.67
|
8.03
|
7.87
|
8.12
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
55.53
|
53.57
|
42.49
|
34.43
|
30.51
|
23.75
|
|
|
|
|
|
|
Dividend per Share (₹)
|
0.21
|
2.00
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
15.03
|
4.84
|
2.51
|
5.36
|
379.34
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
11.64
|
-0.38
|
1.26
|
2.82
|
340.58
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
29.62
|
28.55
|
24.21
|
31.08
|
50.94
|
|
|
|
|
|
|
ROE (%)
|
20.48
|
21.98
|
20.99
|
20.04
|
24.89
|
39.44
|
|
|
|
|
|
|
ROA (%)
|
33.59
|
18.06
|
16.64
|
16.04
|
20.11
|
28.79
|
|
|
|
|
|
|
EBIT Margin (%)
|
32.73
|
32.95
|
31.53
|
29.82
|
33.98
|
41.37
|
|
|
|
|
|
|
Net Margin (%)
|
26.66
|
25.95
|
23.38
|
24.77
|
33.73
|
31.68
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
33.25
|
29.21
|
31.64
|
42.47
|
37.63
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-2.14
|
15.17
|
29.96
|
34.29
|
-14.16
|
11.60
|
|
|
|
|
|
|
EBIT Growth (%)
|
1.71
|
20.33
|
37.42
|
17.85
|
-29.48
|
47.50
|
|
|
|
|
|
|
Net Profit Growth (%)
|
17.57
|
31.14
|
22.86
|
-4.64
|
-5.02
|
49.48
|
|
|
|
|
|
|
EPS Growth (%)
|
13.66
|
30.53
|
22.85
|
-2.69
|
-5.03
|
44.52
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
26.67
|
23.43
|
10.57
|
28.46
|
93.17
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
93.25
|
62.29
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Price / Book Value
|
17.16
|
12.25
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.21
|
0.30
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
56.25
|
37.02
|
0.06
|
0.28
|
-0.20
|
-0.49
|
|
|
|
|
|
|
Close Price (₹)
|
770.55
|
656.25
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
High Price (₹)
|
873.50
|
873.50
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Low Price (₹)
|
570.00
|
570.00
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
53,704.22
|
36,865.25
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.01
|
0.02
|
0.05
|
0.12
|
0.07
|
0.03
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.00
|
0.02
|
0.06
|
0.02
|
0.02
|
|
|
|
|
|
|
Current Ratio
|
5.54
|
3.79
|
3.39
|
3.49
|
5.16
|
3.48
|
|
|
|
|
|
|
Quick Ratio
|
5.15
|
3.55
|
2.69
|
3.03
|
4.69
|
3.32
|
|
|
|
|
|
|
Interest Coverage
|
127.84
|
117.83
|
63.40
|
50.43
|
58.01
|
45.81
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-17 | Mar-16 | Mar-15 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
29.49
|
27.80
|
24.42
|
34.55
|
25.93
|
26.49
|
|
|
|
|
|
|
Asset Turnover
|
1.17
|
0.67
|
0.68
|
0.62
|
0.55
|
0.87
|
|
|
|
|
|
|
Receivable days
|
--
|
87.02
|
92.78
|
98.30
|
103.65
|
86.09
|
|
|
|
|
|
|
Inventory Days
|
--
|
38.87
|
54.41
|
43.81
|
32.40
|
13.83
|
|
|
|
|
|
|
Payable days
|
--
|
41.63
|
51.72
|
52.56
|
73.58
|
63.27
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
84.26
|
95.47
|
89.55
|
62.47
|
36.65
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
